{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:08:15Z","timestamp":1778785695798,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Meningiomas are common brain tumours that are usually defined by benign clinical course. However, some meningiomas undergo a malignant transformation and recur within a short time period regardless of their World Health Organization (WHO) grade. The current study aimed to identify potential markers that can discriminate between benign and malignant meningioma courses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We profiled the metabolites from 43 patients with low- and high-grade meningiomas. Tumour specimens were analyzed by nuclear magnetic resonance analysis; 270 metabolites were identified and clustered with the AutoPipe algorithm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We observed two distinct clusters marked by alterations in glycine\/serine and choline\/tryptophan metabolism. Glycine\/serine cluster showed significantly lower WHO grades and proliferation rates. Also progression-free survival was significantly longer in the glycine\/serine cluster.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings suggest that alterations in glycine\/serine metabolism are associated with lower proliferation and more recurrent tumours. Altered choline\/tryptophan metabolism was associated with increases proliferation, and recurrence. Our results suggest that tumour malignancy can be reflected by metabolic alterations, which may support histological classifications to predict the clinical outcome of patients with meningiomas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-021-07887-5","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T15:02:58Z","timestamp":1614610978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Metabolic alterations in meningioma reflect the clinical course"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5581-8764","authenticated-orcid":false,"given":"Waseem","family":"Masalha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karam","family":"Daka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Woerner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Pompe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Delev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie T.","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter Henrik","family":"Heiland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juergen","family":"Grauvogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"7887_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","volume":"122","author":"L Rogers","year":"2015","unstructured":"Rogers L, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg. 2015;122:4\u201323.","journal-title":"J Neurosurg"},{"key":"7887_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803\u201320.","journal-title":"Acta Neuropathol"},{"key":"7887_CR3","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ng.3651","volume":"48","author":"VE Clark","year":"2016","unstructured":"Clark VE, et al. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat Genet. 2016;48:1253\u20139.","journal-title":"Nat Genet"},{"key":"7887_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng.2526","volume":"45","author":"PK Brastianos","year":"2013","unstructured":"Brastianos PK, et al. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet. 2013;45:285\u20139.","journal-title":"Nat Genet"},{"key":"7887_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11060-007-9498-9","volume":"87","author":"WK Pfisterer","year":"2008","unstructured":"Pfisterer WK, et al. Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue. J Neuro-Oncol. 2008;87:43\u201350.","journal-title":"J Neuro-Oncol"},{"key":"7887_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054114","volume":"8","author":"F Gao","year":"2013","unstructured":"Gao F, et al. DNA methylation in the malignant transformation of meningiomas. PLoS One. 2013;8:e54114.","journal-title":"PLoS One"},{"key":"7887_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/bpa.12110","volume":"24","author":"S Goutagny","year":"2014","unstructured":"Goutagny S, et al. High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression. Brain Pathol. 2014;24:184\u20139.","journal-title":"Brain Pathol"},{"key":"7887_CR8","doi-asserted-by":"crossref","unstructured":"Dunn J, et al. Integration and comparison of transcriptomic and proteomic data for meningioma. Cancers (Basel). 2020;12:3270.","DOI":"10.3390\/cancers12113270"},{"key":"7887_CR9","doi-asserted-by":"publisher","first-page":"8426","DOI":"10.1158\/0008-5472.CAN-10-1498","volume":"70","author":"D Monle\u00f3n","year":"2010","unstructured":"Monle\u00f3n D, et al. Metabolic aggressiveness in benign meningiomas with chromosomal instabilities. Cancer Res. 2010;70:8426\u201334.","journal-title":"Cancer Res"},{"key":"7887_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1021\/acs.jproteome.9b00521","volume":"19","author":"L Bender","year":"2020","unstructured":"Bender L, et al. Metabolomic profile of aggressive Meningiomas by using high-resolution magic angle spinning nuclear magnetic resonance. J Proteome Res. 2020;19:292\u20139.","journal-title":"J Proteome Res"},{"key":"7887_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067291","volume":"8","author":"E Serna","year":"2013","unstructured":"Serna E, et al. Gene expression profiles of metabolic aggressiveness and tumor recurrence in benign meningioma. PLoS One. 2013;8:e67291.","journal-title":"PLoS One"},{"key":"7887_CR12","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/neuonc\/nov225.38","volume":"17","author":"E Bosny\u00e1k","year":"2015","unstructured":"Bosny\u00e1k E, et al. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas. Neuro-Oncology. 2015;17:1284\u201392.","journal-title":"Neuro-Oncology"},{"key":"7887_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4161\/cbt.23624","volume":"14","author":"IM Zitron","year":"2013","unstructured":"Zitron IM, Kamson DO, Kiousis S, Juh\u00e1sz C, Mittal S. In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1. Cancer Biol Ther. 2013;14:333\u20139.","journal-title":"Cancer Biol Ther"},{"key":"7887_CR14","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/nprot.2007.376","volume":"2","author":"O Beckonert","year":"2007","unstructured":"Beckonert O, et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc. 2007;2:2692\u2013703.","journal-title":"Nat Protoc"},{"key":"7887_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1006\/jmra.1995.1047","volume":"112","author":"T-L Hwang","year":"1995","unstructured":"Hwang T-L. Water Suppression that Works. Excitation sculping using Arbitrary Waveforms and plused fields gradients. J Magn Reson. 1995;112:275\u20139.","journal-title":"J Magn Reson"},{"key":"7887_CR16","doi-asserted-by":"publisher","first-page":"49178","DOI":"10.18632\/oncotarget.16544","volume":"8","author":"DH Heiland","year":"2017","unstructured":"Heiland DH, et al. The integrative metabolomic-transcriptomic landscape of glioblastome multiforme. Oncotarget. 2017;8:49178\u201390.","journal-title":"Oncotarget"},{"key":"7887_CR17","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/nprot.2014.090","volume":"9","author":"J Hao","year":"2014","unstructured":"Hao J, et al. Bayesian deconvolution and quantification of metabolites in complex 1D NMR spectra using BATMAN. Nat Protoc. 2014;9:1416\u201327.","journal-title":"Nat Protoc"},{"key":"7887_CR18","first-page":"1","volume-title":"Predictive analysis of microarrays","author":"TJ Hastie","year":"2002","unstructured":"Hastie TJ, Narasimhan B, Tibshirani RJ, Chu G. Predictive analysis of microarrays; 2002. p. 1\u201341."},{"key":"7887_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-3242-6","volume-title":"Generalized Linear Models. 500","author":"P McCullagh","year":"1989","unstructured":"McCullagh, P. , Nelder, J. A. Generalized Linear Models. 500 (Chapman & Hall, 1989)."},{"key":"7887_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"key":"7887_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-015-0203-5","volume":"3","author":"IR Holtman","year":"2015","unstructured":"Holtman IR, et al. Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol Commun. 2015;3:31.","journal-title":"Acta Neuropathol Commun"},{"key":"7887_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fgene.2015.00174","volume":"6","author":"OD Iancu","year":"2015","unstructured":"Iancu OD, et al. Cosplicing network analysis of mammalian brain RNA-Seq data utilizing WGCNA and mantel correlations. Front Genet. 2015;6:174.","journal-title":"Front Genet"},{"key":"7887_CR23","doi-asserted-by":"publisher","first-page":"29052","DOI":"10.1038\/srep29052","volume":"6","author":"DH Heiland","year":"2016","unstructured":"Heiland DH, et al. Integrative network-based analysis of magnetic resonance spectroscopy and genome wide expression in Glioblastoma multiforme. Sci Rep. 2016;6:29052.","journal-title":"Sci Rep"},{"key":"7887_CR24","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","volume":"29","author":"W Luo","year":"2013","unstructured":"Luo W, Brouwer C. Pathview: an R\/bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29:1830\u20131.","journal-title":"Bioinformatics"},{"key":"7887_CR25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/neuonc\/nov247","volume":"18","author":"CL Rogers","year":"2016","unstructured":"Rogers CL, et al. Pathology concordance levels for meningioma classification and grading in NRG oncology RTOG trial 0539. Neuro-Oncology. 2016;18:565\u201374.","journal-title":"Neuro-Oncology"},{"key":"7887_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.tibs.2014.02.004","volume":"39","author":"I Amelio","year":"2014","unstructured":"Amelio I, Cutruzzol\u00e1 F, Antonov A, Agostini M, Melino G. Serine and glycine metabolism in cancer. Trends Biochem Sci. 2014;39:191\u20138.","journal-title":"Trends Biochem Sci"},{"key":"7887_CR27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature12752","volume":"502","author":"P Gut","year":"2013","unstructured":"Gut P, Verdin E. The nexus of chromatin regulation and intermediary metabolism. Nature. 2013;502:489\u201398.","journal-title":"Nature"},{"key":"7887_CR28","first-page":"1825","volume":"58","author":"L Cheng","year":"1998","unstructured":"Cheng L, Chang I-W, Louis D, Gonzalez G. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor Specimens1. Cancer Res. 1998;58:1825\u201332.","journal-title":"Cancer Res"},{"key":"7887_CR29","doi-asserted-by":"publisher","DOI":"10.3171\/2009.11.FOCUS09216","volume":"28","author":"WK Pfisterer","year":"2010","unstructured":"Pfisterer WK, et al. Using ex vivo proton magnetic resonance spectroscopy to reveal associations between biochemical and biological features of meningiomas. Neurosurg Focus. 2010;28:E12.","journal-title":"Neurosurg Focus"},{"key":"7887_CR30","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1227\/01.neu.0000303201.62123.5c","volume":"61","author":"WK Pfisterer","year":"2007","unstructured":"Pfisterer WK, et al. Fluorescent in situ hybridization and ex vivo 1H magnetic resonance spectroscopic examinations of meningioma tumor tissue: is it possible to identify a clinically-aggressive subset of benign meningiomas? Neurosurgery. 2007;61:1048\u201359; discussion 1060.","journal-title":"Neurosurgery"},{"key":"7887_CR31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/mrm.1910320306","volume":"32","author":"RJ Gillies","year":"1994","unstructured":"Gillies RJ, Barry JA, Ross BD. In vitro and in vivo 13C and 31P NMR analyses of phosphocholine metabolism in rat glioma cells. Magn Reson Med. 1994;32:310\u20138.","journal-title":"Magn Reson Med"},{"key":"7887_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nm0396-323","volume":"2","author":"M Preul","year":"1996","unstructured":"Preul M, et al. Accurate, nonivasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med. 1996;2:323\u20135.","journal-title":"Nat Med"},{"key":"7887_CR33","first-page":"2277","volume":"7","author":"G Mishra","year":"2018","unstructured":"Mishra G, Phatak S, Kakde D. Role of magnetic resonance spectroscopy in classifying MENINGIOMAS with HIST op a THOLOGICAL CORRELA TION. Int J Sci Res. 2018;7:2277\u20138179.","journal-title":"Int J Sci Res"},{"key":"7887_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0378-4347(00)81604-7","volume":"180","author":"IN Mefford","year":"1980","unstructured":"Mefford IN, Barchas JD. Determination of tryptophan and metabolites in rat brain and pineal tissue by reversed-phase high-performance liquid chromatography with electrochemical detection. J Chromatogr. 1980;180:187\u201393.","journal-title":"J Chromatogr"},{"key":"7887_CR35","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.1158\/0008-5472.CAN-07-1872","volume":"67","author":"R Metz","year":"2007","unstructured":"Metz R, et al. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 2007;67:7082\u20137.","journal-title":"Cancer Res"},{"key":"7887_CR36","first-page":"1320","volume":"21","author":"RA de Jong","year":"2011","unstructured":"de Jong RA, et al. Serum tryptophan and kynurenine concentrations as parameters for indoleamine 2,3-dioxygenase activity in patients with endometrial, ovarian, and vulvar cancer. Int J Gynecol Cancer. 2011;21:1320\u20137.","journal-title":"Int J Gynecol Cancer"},{"key":"7887_CR37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4137\/IJTR.S4157","volume":"3","author":"R Sucher","year":"2010","unstructured":"Sucher R, et al. IDO-mediated tryptophan degradation in the pathogenesis of malignant tumor disease. Int J Tryptophan Res. 2010;3:113\u201320.","journal-title":"Int J Tryptophan Res"},{"key":"7887_CR38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/478192a","volume":"478","author":"G Prendergast","year":"2011","unstructured":"Prendergast G, Cancer C. Why tumours eat tryptophan. Nature. 2011;478:192\u20134.","journal-title":"Nature"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07887-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-07887-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07887-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T09:03:55Z","timestamp":1621587835000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-07887-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["7887"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-07887-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-87461\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]},"assertion":[{"value":"29 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Open Access funding statement has been added to the funding section of this article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For this study, we included 43 patients who underwent surgery at the Department of Neurosurgery of the Medical Center, University of Freiburg. The local ethics committee of the University of Freiburg approved the data evaluation, imaging procedures, and experimental design (protocols 100020\/09 and 5565\/15). The methods were carried out in accordance with the approved guidelines. Written informed consent was obtained from each patient. The studies were approved by an institutional review board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No potential conflicts of interest were disclosed by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}